Cardiac thromboxane A2 receptor activation does not directly induce cardiomyocyte hypertrophy but does cause cell death that is prevented with gentamicin and 2-APB

por Touchberry, Chad D, Silswal, Neerupma, Tchikrizov, Vladimir, Elmore, Christopher J, Srinivas, Shubra, Akthar, Adil S, Swan, Hannah K, Wetmore, Lori A, Wacker, Michael J
Publicado en BMC Pharmacol Toxicol (2014)

FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy

por Touchberry, Chad D., Green, Troy M., Tchikrizov, Vladimir, Mannix, Jaimee E., Mao, Tiffany F., Carney, Brandon W., Girgis, Magdy, Vincent, Robert J., Wetmore, Lori A., Dawn, Buddhadeb, Bonewald, Lynda F., Stubbs, Jason R., Wacker, Michael J.
Publicado 2013